Tell Ulcerative Colitis Patients Entyvio Doesn't Seem to Cause Immunosuppression
Entyvio (en-TIH-vee-oh, vedolizumab) is a new biologic option for treating ulcerative colitis in adults.
It's also approved for treating Crohn's disease in the U.S. and Europe...but not yet in Canada.
Entyvio is an integrin inhibitor...similar to Tysabri (natalizumab) for multiple sclerosis. But Entyvio is selective for the gut.